Evidence map›Paper›PMID 42630720›Full record

ArticleFrontiers in psychiatry2026

Case Report: A novel

Anja G Bos-Roubos, Rosalie Te Brinke, Anja A Kattentidt-Mouravieva, Rolph Pfundt, Laura C G de Graaff, Ellen Wingbermühle, Jos I M Egger

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Anja G Bos-RoubosCenter of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands.
Rosalie Te BrinkeCenter of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands.
Anja A Kattentidt-MouravievaStichting Zuidwester, Middelharnis, Netherlands.
Rolph PfundtHuman Genetics, Radboud University Medical Center, Nijmegen, Netherlands.
Laura C G de GraaffCenter for Adults with Rare Genetic Syndromes, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, Netherlands.
Ellen WingbermühleCenter of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands.
Jos I M EggerCenter of Excellence for Neuropsychiatry, Vincent van Gogh Institute for Psychiatry, Venray, Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report describes the diagnostic and treatment course of an adult woman with the ultra-rare Au-Kline syndrome (AUKS). Since the age of 32 years, when the syndrome was yet undiagnosed, the patient suffered from behavioral decline coinciding with changes in living conditions. At the age of 38, following a bladder infection, she presented with a delirium for which antipsychotic medication was started. The delirium resolved but, while the medication was continued, the pre-existing behavioral symptoms persisted. Clinicpal genetic evaluation revealed a history of congenital hypotonia, developmental delay, and multiple (craniofacial) dysmorphisms. Subsequent trio-based genetic testing demonstrated a novel pathogenic variant in the

Indexed as

Au-Kline syndromecase reportcontextual neuropsychologygenetic testingpsychomotor interventions

Identifiers

PMID42630720
PMCPMC13494470

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.